Main content area

Induction of apoptosis in HepG2 human hepatocellular carcinoma cells by a novel derivative of ursodeoxycholic acid (UDCA)

Park, Yoo-Hoi, Kim, Jung-Ae, Baek, Jin-Hyen, Jung, Eun-Jin, Kim, Tae-Hyong, Suh, Hongsuk, Park, Myung-Hwan, Kim, Kyu-Won
Archives of pharmacal research 1997 v.20 no.1 pp. 29-33
DNA fragmentation, apoptosis, drug therapy, hepatocytes, hepatoma, human cell lines, humans, neoplasm cells, shrinkage, ursodeoxycholic acid
The effects of ursodeoxycholic acid (UDCA) and its novel derivative, named as HS-1030, on the proliferation of HepG2, human hepatocellular carcinoma cells were investigated. Whereas UDCA had no significant effect in a concentration range we have tested, HS-1030 inhibited the proliferation of HepG2 cells in a concentration dependent manner. Surprisingly, HS-1030 had no effect on the proliferation of Human Chang liver cell which is a normal liver cell line. We also found that proliferation-inhibitory effect of HS-1030 was due to the induction of apoptosis of HepG2 cells, which was confirmed by observing the internucleosomal DNA fragmentation and morphological changes (i.e. cell shrinkage, nuclear condensation and the formation of apoptotic bodies). These results suggest that HS-1030 may be a good candidate as a drug for the treatment of liver cancer.